卵巢癌的教科书结局及其对生存的影响:比较研究
Silvia Carbonell-Morote1,2, Alvaro Arjona-Sánchez3, Pedro Antonio Cascales-Campos4,5
1Universidad Miguel Hernández, Alicante, Spain.
World journal of surgical oncology
|February 1, 2025
概括
在卵巢癌外科手术后实现教科书结局 (TO) 与腹癌显著改善了患者的生存率. 这项研究强调了TO作为评估手术结果和在各中心比较结果的宝贵工具.
科学领域:
- 妇科瘤学 妇科瘤学
- 手术瘤学手术瘤学
- 腹癌研究 腹癌研究
背景情况:
- 教科书结局 (TO) 与瘤患者的生存率改善有关.
- 对于接受手术的腹癌患者的卵巢癌的TO存在有限的数据.
- 这项研究调查了在患有卵巢癌的卵巢癌患者中进行间隔手术的TO,包括或不包括HIPEC (TOOC).
研究的目的:
- 为了研究在患有腹膜癌症 (TOOC) 的卵巢癌患者中实现教科书结果.
- 评估实现TOOC对整体存活率的影响.
- 识别影响TOOC实现的因素.
主要方法:
- 2010年至2015年间进行的多中心研究.
- 纳入标准:患有卵巢癌和腹癌的18岁以上患者,经过neoadjuvant治疗后.
- TOOC标准:没有重大并发症,没有死亡率,没有长期停留 (≤10天),完全细胞减小 (CC-0),没有再录取.
主要成果:
- 365名患者中有204名 (55.9%) 获得了TOOC.
- 在85.5%的患者中,实现了完整的细胞减少 (CC-0).
- TOOC与明显更好的整体存活率相关 (41个月与27个月相比,p<0.0001).
- 影响TOOC的因素包括术后的PCI,年龄,HIPEC和手术的持续时间.
结论:
- 教科书结果 (TO) 是评估和比较卵巢癌与腹癌的手术结果的实用指标.
- 实现TOOC与这些患者的整体存活率提高有关.
- TOOC 作为一个有价值的管理工具,用于执行细胞还原手术的中心.
相关概念视频
Cancer Survival Analysis
321
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
321
Comparing the Survival Analysis of Two or More Groups
131
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
131
Kaplan-Meier Approach
80
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
80


